MyDoc named 2020 Singapore Telehealth Company of the Year by Frost & Sullivan

MyDoc, a Singapore based digital healthcare company, has recently been named 2020 Singapore Telehealth Company of the Year by Frost & Sullivan.
MyDoc named 2020 Singapore Telehealth Company of the Year by Frost & Sullivan

Founded in 2012, MyDoc is leveraging technology to create an integrated and comprehensive online-offline ecosystem for healthcare. Through strategic partnerships with various stakeholders across the industry, MyDoc is removing the inefficiencies in the current healthcare system, with the aim to make healthcare more accessible to everyone.

Dr Snehal Patel, CEO and co-Founder of MyDoc, said, "It is an enormous honour to be evaluated as a leader in this space by Frost and Sullivan, a consultancy that has such deep expertise in healthcare. We profoundly appreciate the recognition of our team's hard work in setting the standard for quality digital health in Singapore, and more broadly across Southeast Asia."

"With a strong pipeline of innovation, we are determined to blaze a path forward in the coming years. We are committed to help set in place a model that will make sustainable, accountable and value-based care a reality for millions," he continued.

"MyDoc displays exemplary leadership and addresses unmet needs in the Singapore telehealth industry by digitalising healthcare through its telehealth platform. Its strong regional presence in eight markets, i.e., Singapore, Hong Kong, S.A.R., China, Malaysia, Sri Lanka, Vietnam, Thailand, India and the Philippines, has gained MyDoc the trust of renowned healthcare participants, including global insurers, leading regional pharmacy chains, and technology players," said Aliya Zulkafli, Research Associate for Best Practices, Frost & Sullivan.

"Having pioneered numerous Asian telehealth partnerships, coupled with its unique value proposition of empowering employers, insurers, and providers to improve the quality of care at a lower cost, MyDoc has been at the forefront in furthering its growth in Singapore telehealth," she added.

The recipients of the annual Frost & Sullivan Asia-Pacific Best Practices Awards were identified based on in-depth research conducted by Frost & Sullivan's analysts. The award categories offered each year are carefully reviewed and evaluated to reflect the current market landscape and include new emerging trends. The short-listed companies were evaluated on a variety of actual market performance indicators, which include revenue growth, market share and growth in market share, leadership in product innovation, marketing strategy and business development strategy.

About MyDoc

MyDoc is a digital healthcare platform that delivers the right care at the right time.

Combining the latest in healthcare technologies and a GP-led coordinated care clinical triage, MyDoc continuously steers patients onto personal care pathways that lead to better health outcomes at lower costs.

Through MyDoc, employees and their dependents stay connected with a team of licensed allied healthcare professionals. Patients covered by corporate and personal healthcare plans from six of the largest health insurers in the region enjoy a convenient cashless care journey.

Established in 2012, MyDoc's integrated online-to-offline ecosystem is used by employees of over 200 Fortune 500 companies and insurance policyholders across eight markets in Asia. MyDoc is backed by a UST Global, a Temasek-backed global B2B technology provider.

With MyDoc, every patient receives the right care at the right time. Anytime, anywhere.

About Frost & Sullivan

For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Register as Visitor to CPhI China 2020!

-----------------------------------------------------------------------
Editor's Note:

En-CPhI.CN is a vertical B2B online trade platform serving the pharmaceutical industry,

for any copyright disputes involved in the reproduced articles,

please email: Julia.Zhang@ubmsinoexpo.com to motify or remove the content.